The diagnostic value of the liquid biopsy in the colon cancer.
메타분석
1/5 보강
[INTRODUCTION] The utility of liquid biopsy in the screening and the follow-up of many cancers and mainly CRC has been reported by many authors.
- 연구 설계 meta-analysis
APA
Mlika M, Zorgati MM, et al. (2025). The diagnostic value of the liquid biopsy in the colon cancer.. Future science OA, 11(1), 2590381. https://doi.org/10.1080/20565623.2025.2590381
MLA
Mlika M, et al.. "The diagnostic value of the liquid biopsy in the colon cancer.." Future science OA, vol. 11, no. 1, 2025, pp. 2590381.
PMID
41251116 ↗
Abstract 한글 요약
[INTRODUCTION] The utility of liquid biopsy in the screening and the follow-up of many cancers and mainly CRC has been reported by many authors. Our aim was to assess its diagnostic yield as a surrogate of tissue biopsy in CRC.
[METHODS] The authors performed a meta-analysis according to the PRISMA recommendations. Publication bias was evaluated using the Funnel plot followed by the Egger regression test. Meta-disc 2.0 was used. In order to assess the heterogeneity, the Cochrane Chi 2 test (Q-test), Tau2 and 95% prediction interval (PI) were calculated (CMA version 4).
[RESULTS] Our results revealed a high diagnostic potential of the liquid biopsy in CRC with a pooled SEN, SPE, PLR, NLR and DOR accounting respectively for 77%, 94.3%, 6.85, 0.26 and 26.467. The AUC accounted for 0.97. Based on the prediction interval analysis, we observed an important heterogeneity. The meta-regression analysis revealed the sample nature (plasma), the biomarker used (cfDNA) and the intake of a preoperative treatment as potential moderators.
[CONCLUSION] Even if our results highlighted a high diagnostic potential of liquid biopsy in the diagnosis of CRC, the heterogeneity observed reinforces the need to harmonize the use of particular samples, the biomarker assessed and to make attention to the treatment intake before surgery.
[METHODS] The authors performed a meta-analysis according to the PRISMA recommendations. Publication bias was evaluated using the Funnel plot followed by the Egger regression test. Meta-disc 2.0 was used. In order to assess the heterogeneity, the Cochrane Chi 2 test (Q-test), Tau2 and 95% prediction interval (PI) were calculated (CMA version 4).
[RESULTS] Our results revealed a high diagnostic potential of the liquid biopsy in CRC with a pooled SEN, SPE, PLR, NLR and DOR accounting respectively for 77%, 94.3%, 6.85, 0.26 and 26.467. The AUC accounted for 0.97. Based on the prediction interval analysis, we observed an important heterogeneity. The meta-regression analysis revealed the sample nature (plasma), the biomarker used (cfDNA) and the intake of a preoperative treatment as potential moderators.
[CONCLUSION] Even if our results highlighted a high diagnostic potential of liquid biopsy in the diagnosis of CRC, the heterogeneity observed reinforces the need to harmonize the use of particular samples, the biomarker assessed and to make attention to the treatment intake before surgery.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy.